乌尔索利克酸的诱人的旅程:一个Triterpenoid与癌症的标志
Youness Limami1,2, Aline Pinon3, Hicham Wahnou2
1Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco.
Molecules (Basel, Switzerland)
|December 9, 2023
概括
酸 (UA) 是一种天然化合物,通过抑制癌症的特征,如扩散和转移,显示出作为多目标癌症治疗的希望. 需要进一步的研究来克服UA.
科学领域:
- 在瘤学瘤学.
- 自然产品化学 自然产品化学
- 分子生物学分子生物学
背景情况:
- 癌症是一种复杂的疾病,具有多种特征,通常由传统的单一向疗法不足以解决.
- 耐药性和有限的疗效需要新的治疗策略,同时针对多种癌症特征.
- 乌尔索酸 (UA) 是一种天然的五环三基,已成为多目标癌症治疗的潜在候选者.
研究的目的:
- 审查和总结目前对乌尔索酸抗癌性质的理解.
- 专注于UA调节多种癌症特征的能力.
- 讨论UA抗癌作用背后的分子标和信号通路.
主要方法:
- 关于研究乌尔索酸抗癌活性的综合文献综述.
- 分析详细介绍UA对癌症特征的影响的研究,如扩散,亡,血管新生和转移.
- 通过UA调节的分子标和信号通路 (例如PI3K/Akt,MAPK/ERK,NF-κB,Wnt/β-catenin) 的检查.
主要成果:
- 乌尔索酸在各种癌症类型 (乳腺,肺,前列腺,结肠,肝脏) 中表现出强大的抗癌作用.
- UA抑制了癌症的关键特征,包括细胞增殖,血管生成,侵袭和转移,同时诱导了细胞亡.
- UA调节涉及癌症进展的关键信号通路,并表现出多目标机制,如亡和自诱导.
结论:
- 乌尔索酸是用于多目标癌症治疗的有希望的天然化合物,因为它对癌症特征具有广泛的活性.
- UA的有效性源于其干扰多种癌症驱动途径和细胞过程的能力.
- UA的低生物可用性是一个挑战,突出了提高其治疗潜力的战略的需要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs for Treatment of Ulcerative Colitis in IBD
145
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
145
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K


